Navigation Links
InfuSystem Holdings Appoints Two New Board Members
Date:4/28/2008

of care all play a role in the growing trend toward this form of treatment. InfuSystem's pumps are primarily used for colorectal cancer, but they have been approved for other forms of cancer, thereby greatly enhancing the market opportunity for InfuSystem.

Forward-Looking Statements

Except for the historical information contained herein, the matters discussed in this press release are forward-looking statements that involve risks and uncertainties that could cause actual results to differ materially from those predicted by such forward-looking statements. These risks and uncertainties include general economic conditions, as well as other risks detailed from time to time in InfuSystem's publicly filed documents.


'/>"/>
SOURCE InfuSystem Holdings, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. Hill-Rom Holdings, Inc. Invites You to Join Its Fiscal 2008 Second Quarter Earnings Webcast
2. Agreement Executed for Amneal Pharmaceuticals to Acquire the Assets of Interpharm Holdings
3. Zimmer Holdings, Inc. Reports First Quarter Financial Results
4. NightHawk Radiology Holdings, Inc. to Host Conference Call to Discuss First Quarter 2008 Earnings Results
5. Lincare Holdings Inc. Announces First Quarter 2008 Financial Results
6. Zimmer Holdings to Present at Morgan Stanley Healthcare Unplugged Conference
7. HMS Holdings Corp. Hosts First Quarter 2008 Financial Teleconference and Presentation
8. PainCare Holdings Reports on Fiscal Year 2007 Results
9. LifeCare Holdings, Inc. Names McAlister Chairman and CEO
10. Duane Reade Holdings, Inc. Announces Resignation of Chief Marketing Officer
11. Eurosport Active World, Corp. Announces Reverse Merger Into Eagle International Holdings Group, Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/1/2008)...h wraps up successful disaster relief campaign , ... -- The American Red Cross is asking people across...0 million in 30 days. This holiday season push wil... the Red Cross Campaign for Disaster Relief. Alrea...ce its launch in September, and the Red Cross hope...
(Date:12/1/2008)...Dec. 1 Medication therapy manageme...complished professionals to its,advisory board. ,...include Martin Makary, M.D.;,Michael Burcham; and...of,advisors that has helped PharmMD launch and ho...medication error, misuse, overuse and abuse. MTM ...
(Date:12/1/2008)...ec. 1 The United States...s new right hand on Saturday, November 29, as Dr. ...n, changed the bandages. , , "Wow, it looks...rom his room at Jewish Hospital. "It,s awesome," ... , Hondusky, a New York resident, went on to s...
(Date:12/1/2008)...e implant makes it more difficult to treat the mal.... 1 (HealthDay News) -- Women who have had their b...osed with early-stage breast cancer may be treated...tment known as brachytherapy, according to an Ariz...allenge to take care of these augmented women," sa...
Breaking Medicine News(10 mins):Health News:Red Cross Asks America to Help Raise $30 Million in 30 Days 2Health News:Red Cross Asks America to Help Raise $30 Million in 30 Days 3Health News:PharmMD Expands Advisory Board 2Health News:Fifth U.S. Hand Transplant Patient Gets Look at New Hand 2Health News:Radioactive 'Seed' Rx Helps Women With Implants Fight Breast Cancer 2Health News:Radioactive 'Seed' Rx Helps Women With Implants Fight Breast Cancer 3
...esearchers at the Stanford University School of Me...he researchers found that children with post-traum... hormone cortisol were likely to experience a decr...re important in memory processing and emotion. ...
...one of the reasons why Down syndrome births are hi...cording to senior Queensland health analysts. Mic...imothy Roselli and Heidi Carroll, of Queensland He...th Down syndrome in Queensland to see whether the ...
...an eat excessive amounts of food and not gain weig...more likely to develop obesity and this most commo...sed two strains of mice with differing tendencies ... diet, identified genetic and cellular mechanisms ...
...national waiting list for kidney transplants have ... matter how long they are on the list. Due to prio...these patients have developed antibodies that make...donor organs. Researchers at Emory University hav...
Other Medicine News:Health News:Severe PTSD Damages Children's Brains: Study 2Health News:Severe PTSD Damages Children's Brains: Study 3Health News:Down Syndrome Testing for All Mums? 2Health News:Study Finds Fat Type That can Protect Against Weight Gain and Diabetes 2Health News:Study Finds Fat Type That can Protect Against Weight Gain and Diabetes 3Health News:Research Improves Kidney Transplant Chances for Sensitized Patients 2Health News:Research Improves Kidney Transplant Chances for Sensitized Patients 3
(Date:11/28/2008)..., Nov. 28 Eli Lilly and ...ntal New Drug Application (sNDA) from,the U.S. Fo...duloxetine HCl),for the management of chronic pai... first half of 2009, adding data from a recently c... pain of the knee. , The decision does not ...
(Date:11/25/2008)...eness can improve recovery , , Audio and We...lable on the Mayo Clinic News Blog. Please see the... ROCHESTER, Minn., Nov. 25 /PRNewswire-USNewswir...ke patients don,t think they,re having a stroke --...their condition worsens. The findings appear in th...
(Date:11/25/2008)...alif., Nov. 25 Pharmacyc... the company has completed a Phase 1,clinical tri...lass,small-molecule Factor VIIa inhibitor. The tr...ers to evaluate the safety and pharmacologic effec...483 resulted in a linear dose,response in the Int...
(Date:11/24/2008)...N.J., Nov. 24 Leaders of...provided an update for investors on the company,s ...ive portfolio that includes 46 new entities in cli...preclinical studies. , , "Research and deve...-Plough as we continue our transformation," said F...
Breaking Medicine Technology:Lilly Withdraws Application for Additional U.S. Indication for Cymbalta(R) for Chronic Pain 2Lilly Withdraws Application for Additional U.S. Indication for Cymbalta(R) for Chronic Pain 3Lilly Withdraws Application for Additional U.S. Indication for Cymbalta(R) for Chronic Pain 4Do You Know You're Having a Stroke? 2Do You Know You're Having a Stroke? 3Pharmacyclics Announces Completion of Phase 1 Clinical Trial of Factor VIIa Inhibitor PCI-27483 2Pharmacyclics Announces Completion of Phase 1 Clinical Trial of Factor VIIa Inhibitor PCI-27483 3Pharmacyclics Announces Completion of Phase 1 Clinical Trial of Factor VIIa Inhibitor PCI-27483 4Schering-Plough Highlights R&D Pipeline Progress, Innovation and Breadth of Research Projects 2Schering-Plough Highlights R&D Pipeline Progress, Innovation and Breadth of Research Projects 3Schering-Plough Highlights R&D Pipeline Progress, Innovation and Breadth of Research Projects 4Schering-Plough Highlights R&D Pipeline Progress, Innovation and Breadth of Research Projects 5Lettuce leafy greens and E coli 370 1Lettuce leafy greens and E coli 370 2Two studies published in the Lancet 366 1Two studies published in the Lancet 366 2New Study Findings Confirm CLEXANE 28R 29 LOVENOX 28R 29 Long Term Clinical Benefit in Patients Suffering From Acute Coronary Syndrome 310 1New Study Findings Confirm CLEXANE 28R 29 LOVENOX 28R 29 Long Term Clinical Benefit in Patients Suffering From Acute Coronary Syndrome 310 2New Study Findings Confirm CLEXANE 28R 29 LOVENOX 28R 29 Long Term Clinical Benefit in Patients Suffering From Acute Coronary Syndrome 310 3New Study Findings Confirm CLEXANE 28R 29 LOVENOX 28R 29 Long Term Clinical Benefit in Patients Suffering From Acute Coronary Syndrome 310 4New Study Findings Confirm CLEXANE 28R 29 LOVENOX 28R 29 Long Term Clinical Benefit in Patients Suffering From Acute Coronary Syndrome 310 5Report recommends off site disposal of secondary waste 307 1Report recommends off site disposal of secondary waste 307 2Report recommends off site disposal of secondary waste 307 3Report recommends off site disposal of secondary waste 307 4
...WSWIRE) -- New data,presented at ECCMID highlight ...f Basilea,s (SWX:BSLN) two late-stage,drug candida...ed,both for ceftobiprole, the first anti-MRSA broa..., and for isavuconazole, a,novel azole for the tre...her data on their respective breadths of spectrum,...
...- Novagali Pharma, an,emerging ophthalmic pharmace...nces today positive results from the Phase III,cli...om Vernal,Keratoconjunctivitis (VKC). In this orph...gns of disease improved in patients,receiving Veka...),was excellent. , VKC is a severe form of chronic...
Other Medicine Technology:Scientific Results Presented At ECCMID Demonstrate Well-,Differentiated Profile of Basilea's Two Phase III Anti- infective,Compounds 2Scientific Results Presented At ECCMID Demonstrate Well-,Differentiated Profile of Basilea's Two Phase III Anti- infective,Compounds 3Scientific Results Presented At ECCMID Demonstrate Well-,Differentiated Profile of Basilea's Two Phase III Anti- infective,Compounds 4Scientific Results Presented At ECCMID Demonstrate Well-,Differentiated Profile of Basilea's Two Phase III Anti- infective,Compounds 5Scientific Results Presented At ECCMID Demonstrate Well-,Differentiated Profile of Basilea's Two Phase III Anti- infective,Compounds 6Scientific Results Presented At ECCMID Demonstrate Well-,Differentiated Profile of Basilea's Two Phase III Anti- infective,Compounds 7Novagali Pharma Announces Positive Vekacia Clinical Results From,Pivotal Phase III Trial in Vernal Keratoconjunctivitis 2
...2.8mm instrument channel for superb versatility in...ion of a wide variety of accessories including tho...is model features excellent optics with a wide fie... also provides improved operability, increased BAL...
...ofiberscopes with electrosurgical capability, has ...nd for expanded bronchoscopic diagnostic and treat...l section and ergonomic design to facilitate incre...eld of view, a smaller insertion tube and distal e...
Facilitates one-lung ventilation when using dual lumen endobronchial tubes.
Double lumen tubes for selective one-lung ventilation., ,Each SHER-I-BRONCH Endobronchial Tube is packaged with pre-loaded stylet, tube-to-circuit adaptors, suction catheters and Accessories Pack (f
Medicine Products: